Type |
Details |
Score |
Publication |
First Author: |
Moreno C |
Year: |
2013 |
Journal: |
J Immunol |
Title: |
Modulation of voltage-dependent and inward rectifier potassium channels by 15-epi-lipoxin-A4 in activated murine macrophages: implications in innate immunity. |
Volume: |
191 |
Issue: |
12 |
Pages: |
6136-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wantha S |
Year: |
2013 |
Journal: |
Circ Res |
Title: |
Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. |
Volume: |
112 |
Issue: |
5 |
Pages: |
792-801 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lämmermann T |
Year: |
2013 |
Journal: |
Nature |
Title: |
Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. |
Volume: |
498 |
Issue: |
7454 |
Pages: |
371-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu X |
Year: |
2016 |
Journal: |
BMC Immunol |
Title: |
Decreased expression levels of Ifi genes is associated to the increased resistance to spontaneous arthritis disease in mice deficiency of IL-1RA. |
Volume: |
17 |
Issue: |
1 |
Pages: |
25 |
|
•
•
•
•
•
|
Publication |
First Author: |
UniProt-GOA |
Year: |
2012 |
|
Title: |
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2002 |
|
Title: |
Chromosome assignment of mouse genes using the Mouse Genome Sequencing Consortium (MGSC) assembly and the ENSEMBL Database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
The Gene Ontology Consortium |
Year: |
2010 |
|
Title: |
Automated transfer of experimentally-verified manual GO annotation data to mouse-human orthologs |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Marc Feuermann, Huaiyu Mi, Pascale Gaudet, Dustin Ebert, Anushya Muruganujan, Paul Thomas |
Year: |
2010 |
|
Title: |
Annotation inferences using phylogenetic trees |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Database and National Center for Biotechnology Information |
Year: |
2000 |
Journal: |
Database Release |
Title: |
Entrez Gene Load |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Bairoch A |
Year: |
1999 |
Journal: |
Database Release |
Title: |
SWISS-PROT Annotated protein sequence database |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and Loading Genome Assembly Coordinates from Ensembl Annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2005 |
|
Title: |
Obtaining and loading genome assembly coordinates from NCBI annotations |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
The Gene Ontology Consortium |
Year: |
2014 |
|
Title: |
Automated transfer of experimentally-verified manual GO annotation data to mouse-rat orthologs |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2003 |
|
Title: |
MGI Sequence Curation Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome U74 Array Platform (A, B, C v2). |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
GemPharmatech |
Year: |
2020 |
|
Title: |
GemPharmatech Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics (MGI) and The National Center for Biotechnology Information (NCBI) |
Year: |
2010 |
Journal: |
Database Download |
Title: |
Consensus CDS project |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Velocigene |
Year: |
2008 |
Journal: |
MGI Direct Data Submission |
Title: |
Alleles produced for the KOMP project by Velocigene (Regeneron Pharmaceuticals) |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wellcome Trust Sanger Institute |
Year: |
2009 |
Journal: |
MGI Direct Data Submission |
Title: |
Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Wellcome Trust Sanger Institute |
Year: |
2010 |
Journal: |
MGI Direct Data Submission |
Title: |
Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Allen Institute for Brain Science |
Year: |
2004 |
Journal: |
Allen Institute |
Title: |
Allen Brain Atlas: mouse riboprobes |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Group |
Year: |
2003 |
Journal: |
Database Procedure |
Title: |
Automatic Encodes (AutoE) Reference |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Mouse Genome Informatics Scientific Curators |
Year: |
2009 |
Journal: |
Database Download |
Title: |
Mouse Microarray Data Integration in Mouse Genome Informatics, the Affymetrix GeneChip Mouse Genome 430 2.0 Array Platform |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
MGD Nomenclature Committee |
Year: |
1995 |
|
Title: |
Nomenclature Committee Use |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Shanghai Model Organisms Center |
Year: |
2017 |
Journal: |
MGI Direct Data Submission |
Title: |
Information obtained from the Shanghai Model Organisms Center (SMOC), Shanghai, China |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Diez-Roux G |
Year: |
2011 |
Journal: |
PLoS Biol |
Title: |
A high-resolution anatomical atlas of the transcriptome in the mouse embryo. |
Volume: |
9 |
Issue: |
1 |
Pages: |
e1000582 |
|
•
•
•
•
•
|
Publication |
First Author: |
Skarnes WC |
Year: |
2011 |
Journal: |
Nature |
Title: |
A conditional knockout resource for the genome-wide study of mouse gene function. |
Volume: |
474 |
Issue: |
7351 |
Pages: |
337-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cyagen Biosciences Inc. |
Year: |
2022 |
|
Title: |
Cyagen Biosciences Website. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Okazaki Y |
Year: |
2002 |
Journal: |
Nature |
Title: |
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. |
Volume: |
420 |
Issue: |
6915 |
Pages: |
563-73 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
351
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Cao T |
Year: |
2017 |
Journal: |
Cell Biol Toxicol |
Title: |
FAM3D inhibits glucagon secretion via MKP1-dependent suppression of ERK1/2 signaling. |
Volume: |
33 |
Issue: |
5 |
Pages: |
457-466 |
|
•
•
•
•
•
|
Publication |
First Author: |
de Wit NJ |
Year: |
2012 |
Journal: |
J Nutr Biochem |
Title: |
Oit1/Fam3D, a gut-secreted protein displaying nutritional status-dependent regulation. |
Volume: |
23 |
Issue: |
11 |
Pages: |
1425-33 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry represents a group of animal proteins, including TAFA-5 from mammals. TAFA-5 is a secreted protein distantly related to the CC-chemokine family. It has been shown to inhibit postinjury neointima formation via sphingosine-1-phosphate receptor 2-G12/13-RhoA signaling []. Together with its target receptor FPR2 can negatively regulate osteoclast formation []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
FAM3D inhibits glucagon secretion via MKP1-dependent suppression of ERK1/2 signaling. As dysregulated glucagon secretion is a characteristic of type 2 diabetes, FAM3D could have a therapeutic potential []. FAM3D is constitutively expressed in the gastrointestinal tract []and could play a role in gastrointestinal homeostasis and inflammation through its receptors FPR1 and FPR2 []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Su SB |
Year: |
1999 |
Journal: |
J Exp Med |
Title: |
A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. |
Volume: |
189 |
Issue: |
2 |
Pages: |
395-402 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gao JL |
Year: |
1999 |
Journal: |
J Exp Med |
Title: |
Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. |
Volume: |
189 |
Issue: |
4 |
Pages: |
657-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schiffmann E |
Year: |
1975 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
N-formylmethionyl peptides as chemoattractants for leucocytes. |
Volume: |
72 |
Issue: |
3 |
Pages: |
1059-62 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kindzelskii AL |
Year: |
1994 |
Journal: |
J Struct Biol |
Title: |
Imaging the spatial distribution of membrane receptors during neutrophil phagocytosis. |
Volume: |
113 |
Issue: |
3 |
Pages: |
191-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Schepetkin IA |
Year: |
2008 |
Journal: |
Mol Pharmacol |
Title: |
Identification of novel formyl peptide receptor-like 1 agonists that induce macrophage tumor necrosis factor alpha production. |
Volume: |
74 |
Issue: |
2 |
Pages: |
392-402 |
|
•
•
•
•
•
|
Publication |
First Author: |
Browning DD |
Year: |
1997 |
Journal: |
J Biol Chem |
Title: |
Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells. |
Volume: |
272 |
Issue: |
12 |
Pages: |
7995-8001 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou Y |
Year: |
2005 |
Journal: |
J Natl Cancer Inst |
Title: |
Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. |
Volume: |
97 |
Issue: |
11 |
Pages: |
823-35 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen DL |
Year: |
2009 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Downregulating FPR restrains xenograft tumors by impairing the angiogenic potential and invasive capability of malignant glioma cells. |
Volume: |
381 |
Issue: |
3 |
Pages: |
448-52 |
|
•
•
•
•
•
|
Publication |
First Author: |
Karlsson J |
Year: |
2005 |
Journal: |
J Leukoc Biol |
Title: |
Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors. |
Volume: |
78 |
Issue: |
3 |
Pages: |
762-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Svensson L |
Year: |
2007 |
Journal: |
Eur J Immunol |
Title: |
House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. |
Volume: |
37 |
Issue: |
7 |
Pages: |
1966-77 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bena S |
Year: |
2012 |
Journal: |
J Biol Chem |
Title: |
Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. |
Volume: |
287 |
Issue: |
29 |
Pages: |
24690-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ye RD |
Year: |
1992 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. |
Volume: |
184 |
Issue: |
2 |
Pages: |
582-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rabiet MJ |
Year: |
2005 |
Journal: |
Eur J Immunol |
Title: |
Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. |
Volume: |
35 |
Issue: |
8 |
Pages: |
2486-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rabiet MJ |
Year: |
2011 |
Journal: |
J Biol Chem |
Title: |
N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation. |
Volume: |
286 |
Issue: |
30 |
Pages: |
26718-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cattaneo F |
Year: |
2013 |
Journal: |
Int J Mol Sci |
Title: |
Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists. |
Volume: |
14 |
Issue: |
4 |
Pages: |
7193-230 |
|
•
•
•
•
•
|
Publication |
First Author: |
Iribarren P |
Year: |
2005 |
Journal: |
Immunol Res |
Title: |
Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease. |
Volume: |
31 |
Issue: |
3 |
Pages: |
165-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Forsman H |
Year: |
2013 |
Journal: |
Biochim Biophys Acta |
Title: |
The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop. |
Volume: |
1833 |
Issue: |
8 |
Pages: |
1914-23 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Formyl peptide receptors (FPR) are members of the rhodopsin-like G-protein coupled receptor family and are involved in chemotaxis [, ]. They were originally identified by their ability to bind N-formyl peptides (typified by fMet-Leu-Phe (fMLP)), produced by the degradation of either bacterial or host cells [, ]but subsequent ligands have been discovered, containing many microbial agonists derived from both bacteria and viruses [, ].FPRs were initially found on leukocytes, but they are expressed in other cells, for example, immature dendritic cells, platelets, microglial cells, astrocytes, fibroblasts and platelets [, ]. FPRs are expressed at high levels on polymorphonuclear and mononuclear phagocytes. Formyl peptide receptors are not only involved in mediating immune cell response to infection, but also act to suppress the immune system under certain conditions []. The main responses elicited upon ligation of formylated peptides, are those of morphological polarization, locomotion, production of reactive-oxygen species and release of proteolytic enzymes []. There are three formyl peptide receptor subtypes, FPR1, FPR2 and FPR3 [, ]. The sequence similarity between FPR1 and FPR2 is high (69%), and although there is a large sequence similarity also between FPR2 and FPR3 (83%), FPR3 can not bind formylated peptides [, ]. This entry represents formyl peptide receptor 1 (FPR1) and Formyl peptide receptor 2 (FPR2).Formyl peptide receptor 1 (FPR1, also known as fMet-Leu-Phe receptor) plays an important role for host defence. This is shown in mice that are devoid of receptor expression, are unable to respond to an infection by Listeria monocytogenes []. The interaction between formyl-methionyl-leucyl phenylalanine (fMLF) and FPR1 triggers a cascade of multiple second messengers through the activation of phospholipase C, phospholipase D and phospholipase A2. This signalling cascade culminates in cell chemotaxis [], phagocytosis [], production of proinflammatory mediators []and activation of transcription factors []. The characterisation of FPR1 function has focused on cells involved in brain function and disease and research indicates that FPR1 is expressed in highly malignant human glioma cells, and is thought to be responsible for mediating motility, growth and angiogenesis of the glioblastoma [, ]. The number of ligands for FPRs is immense, and includes many microbial agonists derived from both bacteria and viruses [, ]. However, unlike FPR2 and FPR3, ligands for FPR1 include endogenous substances, such as annexin AI peptide (Ac9-25) [], and allergens, such as the house mite allergen [].Formyl peptide receptor 2 (FPR2), also known as formyl peptide receptor-like 1 (FPRL1) []and ALXR [], interacts with formylated peptides at a much lower affinity than FPR1 [, ]. However, FPR2 has been found to be a promiscuous receptor, and binds ligands of great diversity in origin and structure, including both lipids and proteins [, ]. It has also been found that mitochondria-derived formyl peptides are potent agonists for FPR2 [], suggesting that its primary function may be to recognise host-driven mitochondrial peptides or possibly other bacterially derived formyl peptides []. FPR2 is also sensitive to cell-penetrating pepducins, unlike FPR1 [].The characterisation of FPR2 function has focused on cells involved in brain function and disease. Research indicates that peptides derived from the protein amyloid beta, which have been shown to stimulate the release of neurotoxic substances from monocytes, do so via FPR2. This suggests that FPR2 is at least partly responsible for proinflammatory destructive activity in brain tissue during Alzheimer's disease [, ]. FPR2 is also critical in mediating homeostasis, inflammation, and epithelial repair processes in the colon []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Migeotte I |
Year: |
2006 |
Journal: |
Cytokine Growth Factor Rev |
Title: |
Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. |
Volume: |
17 |
Issue: |
6 |
Pages: |
501-19 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ye RD |
Year: |
2009 |
Journal: |
Pharmacol Rev |
Title: |
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. |
Volume: |
61 |
Issue: |
2 |
Pages: |
119-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Le Y |
Year: |
2002 |
Journal: |
Trends Immunol |
Title: |
Formyl-peptide receptors revisited. |
Volume: |
23 |
Issue: |
11 |
Pages: |
541-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Panaro MA |
Year: |
2006 |
Journal: |
Immunopharmacol Immunotoxicol |
Title: |
Biological role of the N-formyl peptide receptors. |
Volume: |
28 |
Issue: |
1 |
Pages: |
103-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Braun MC |
Year: |
2001 |
Journal: |
Blood |
Title: |
Activation of the formyl peptide receptor by the HIV-derived peptide T-20 suppresses interleukin-12 p70 production by human monocytes. |
Volume: |
97 |
Issue: |
11 |
Pages: |
3531-6 |
|
•
•
•
•
•
|
Publication |
First Author: |
He HQ |
Year: |
2013 |
Journal: |
Mol Pharmacol |
Title: |
Functional characterization of three mouse formyl peptide receptors. |
Volume: |
83 |
Issue: |
2 |
Pages: |
389-98 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fu H |
Year: |
2006 |
Journal: |
J Leukoc Biol |
Title: |
Ligand recognition and activation of formyl peptide receptors in neutrophils. |
Volume: |
79 |
Issue: |
2 |
Pages: |
247-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gantz I |
Year: |
1996 |
Journal: |
Cytogenet Cell Genet |
Title: |
Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. |
Volume: |
74 |
Issue: |
4 |
Pages: |
286-90 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Formyl peptide receptors (FPR) are members of the rhodopsin-like G-protein coupled receptor family and are involved in chemotaxis [, ]. They were originally identified by their ability to bind N-formyl peptides (typified by fMet-Leu-Phe (fMLP)), produced by the degradation of either bacterial or host cells [, ]but subsequent ligands have been discovered, containing many microbial agonists derived from both bacteria and viruses [, ].FPRs were initially found on leukocytes, but they are expressed in other cells, for example, immature dendritic cells, platelets, microglial cells, astrocytes, fibroblasts and platelets [, ]. FPRs are expressed at high levels on polymorphonuclear and mononuclear phagocytes. Formyl peptide receptors are not only involved in mediating immune cell response to infection, but also act to suppress the immune system under certain conditions []. The main responses elicited upon ligation of formylated peptides, are those of morphological polarization, locomotion, production of reactive-oxygen species and release of proteolytic enzymes []. There are three formyl peptide receptor subtypes, FPR1, FPR2 and FPR3 [, ]. The sequence similarity between FPR1 and FPR2 is high (69%), and although there is a large sequence similarity also between FPR2 and FPR3 (83%), FPR3 can not bind formylated peptides [, ]. This entry includes the formyl peptide receptors and other related receptors such as C3a and C5a anaphylatoxin chemotactic receptors []and G-protein-coupled receptor CMKlR1 []. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
Mus caroli |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|